Joe Fletcher

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when ELI LILLY & Co publishes a filing, an earnings call transcript or a press release.

Get LLY alerts

About Joe Fletcher

Joe Fletcher is recorded as Head of Investor Relations at ELI LILLY & Co (LLY). Joe Fletcher has spoken on 8 earnings calls across 1 company, most recently for ELI LILLY & Co on October 30, 2024. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.

Joe Fletcher on recent calls

“And joining me on today's call are Dave Ricks, Lilly's Chair and CEO; Dr. Dan Skovronsky, Chief Scientific Officer and President of Lilly Immunology; Lucas Montarce, Chief Financial Officer; Anne White, President of Lilly Neuroscience; Ilya Yuffa, President of Lilly International; Jake Van Naarden, President of Lilly…”

Head of Investor Relations, ELI LILLY & Co Q3 FY2024 Earnings Call · October 30, 2024

“And joining me on today's call are Dave Ricks, Lilly's Chairman and CEO; and Dr. Dan Skovronsky, Chief Scientific Officer and President of Lilly Immunology; Gordon Brooks, Interim Chief Financial Officer; Anne White, President of Lilly Neuroscience; Ilya Yuffa, President of Lilly International; Jake Van Naarden…”

Head of Investor Relations, ELI LILLY & Co Q2 FY2024 Earnings Call · August 8, 2024

“And joining me on today's call are Dave Ricks, Lilly's Chair and CEO; Anat Ashkenazi, Chief Financial Officer; Dr. Dan Skovronsky, Chief Scientific Officer and President of Lilly Immunology; Anne White, President of Lilly Neuroscience; Ilya Yuffa, President of Lilly International; Jake Van Naarden, President of Loxo…”

Head of Investor Relations, ELI LILLY & Co Q1 FY2024 Earnings Call · April 30, 2024

“Thanks for joining us for Eli Lilly and Company's Q4 2023 earnings and 2024 guidance call. I'm Joe Fletcher, Senior Vice President of Investor Relations.”

Head of Investor Relations, ELI LILLY & Co Q4 FY2023 Earnings Call · February 6, 2024

“And joining me on today's call are Dave Ricks, Lilly's Chair and CEO; Anat Ashkenazi, Chief Financial Officer; Dr. Dan Skovronsky, Chief Scientific and Medical Officer; Anne White, President of Lilly Neuroscience; Ilya Yuffa, President of Lilly International; Jake Van Naarden, President of Loxo at Lilly; Mike Mason…”

Head of Investor Relations, ELI LILLY & Co Q3 FY2023 Earnings Call · November 2, 2023